Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927327 · ClinicalTrials.gov registry record · NA
Clinical Evaluation Of MP26 Features in Adults
A NA study of Brain Imaging and Whole Body Imaging, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT02927327 is a NA study of Brain Imaging and Whole Body Imaging that has completed, run by GE Healthcare. The registered enrollment target is 61 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02927327, a NA study of Brain Imaging and Whole Body Imaging, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to collect representative clinical images (head and whole-body scans) of demonstrated diagnostic quality using the next-generation SIGNA PET/MR device equipped with investigational software components in adult population. The images and summary data from this study are intended for use in regulatory submission.
Conditions Studied
Interventions
- DEVICE Zero Echo Time (ZTE) scan for head attenuation
- DEVICE Q.Static (Q. MRAC) for respiratory motion correction
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927327
The ClinicalTrials.gov registry entry for NCT02927327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Brain Imaging appearing as the primary indexed condition, and to 2 interventions - of which Zero Echo Time (ZTE) scan for head attenuation is the first listed.
NCT02927327 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02927327 about?
NCT02927327 is a clinical study titled "Clinical Evaluation Of MP26 Features in Adults". The purpose of the study is to collect representative clinical images (head and whole-body scans) of demonstrated diagnostic quality using the next-generation SIGNA PET/MR device equipped with investigational software components in adult population. The images and summary data from this study are in...
What is the current status of trial NCT02927327?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2016-11. Estimated completion is 2017-09-20.
What conditions does trial NCT02927327 study?
This clinical trial studies the following conditions: Brain Imaging, Whole Body Imaging.
What interventions are being tested in trial NCT02927327?
The interventions under investigation include: Zero Echo Time (ZTE) scan for head attenuation (DEVICE), Q.Static (Q. MRAC) for respiratory motion correction (DEVICE).
Who is sponsoring clinical trial NCT02927327?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02927327 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Imaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.